Emerging Medication in Australia: A Promising Hope for Obesity Management ?
Australia is currently observing the arrival of retatrutide, a novel dual GIP and GLP-1 receptor agonist , representing a significant advance in weight loss . Early research findings have demonstrated impressive results, showing greater effectiveness than existing treatments like semaglutide. Whi